<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05053347</url>
  </required_header>
  <id_info>
    <org_study_id>JWY20210916</org_study_id>
    <nct_id>NCT05053347</nct_id>
  </id_info>
  <brief_title>The Effect of Alpha Linolenic Acid Intake on Patients With Elevated Glycemic Status</brief_title>
  <official_title>The Effect of Alpha Linolenic Acid Intake on Patients With Elevated Glycemic Status: a Double-blind Randomized Controlled Cross-over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The findings of previous experiments suggested that alpha linolenic acid (ALA) has been&#xD;
      linked to anti-hyperglycemic, and reducing the risk of diabetes.This is a randomized&#xD;
      double-blind cross-over trial, aims to study the effect of ALA on glycemic status and human&#xD;
      metabolism. Firstly, the investigators will investigate the efficacy of ALA on improving the&#xD;
      indexes of glucose metabolism. Secondly, next generation sequencing (NGS), ultra-high&#xD;
      performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS) and gas&#xD;
      chromatography-mass spectrometry detection will be conducted to explore the role of ALA on&#xD;
      gut microbiota as well as metabolites. Thirdly, single nucleotide polymorphism will be&#xD;
      genotyped by Time-of-flight mass spectrometry to find the gene-environment interaction&#xD;
      effect.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 8, 2021</start_date>
  <completion_date type="Anticipated">September 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes of HbA1c</measure>
    <time_frame>0 week，12th week, 20th week and 32th week in the intervention period</time_frame>
    <description>glycated hemoglobin</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Elevated Blood Sugar</condition>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bread fortified with ALA</intervention_name>
    <description>The participants were asked to take baked bread once a day. The intervention period is about 6 months separated by a two-month washout period. Do not take any other medicine, traditional Chinese medicine, or dietary supplements.</description>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_label>placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bread without ALA</intervention_name>
    <description>The participants were asked to take baked bread once a day. The intervention period is about 6 months separated by a two-month washout period. Do not take any other medicine, traditional Chinese medicine, or dietary supplements.</description>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_label>placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        pre-diabetic or type 2 diabetic patients who are treated with only one oral antidiabetic&#xD;
        agent and whose fasting plasma glucose is lower than 8.4 mmol; age:30-65 years; BMI&#xD;
        :20-35kg/m2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        type 1 diabetic patients; type 2 diabetic patients with insulin treatment； pregnant or&#xD;
        lactating women； adverse effect on intervention； acute or chronic inflammatory conditions;&#xD;
        severe hepatic,kidney or other complications; other situations ineligible to intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 16, 2021</study_first_submitted>
  <study_first_submitted_qc>September 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2021</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Liegang Liu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

